In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.
The study was published in the journal Nature Communications.
One of the greatest challenges in vessel bioengineering is designing a vessel that will grow with its new owner.
In this study, University of Minnesota Department of Biomedical Engineering Professor Robert Tranquillo and his colleagues generated vessel-like tubes in the lab from a post-natal donor’s skin cells and then removed the cells to minimize the chance of rejection. This also means the vessels can be stored and implanted when they are needed, without the need for customized cell growth of the recipient. When implanted in a lamb, the tube was then repopulated by the recipient’s own cells allowing it to grow.
“This might be the first time we have an ‘off-the-shelf’ material that doctors can implant in a patient, and it can grow in the body,” Tranquillo said. “In the future, this could potentially mean one surgery instead of five or more surgeries that some children with heart defects have before adulthood.”
To develop the material for this study, researchers combined sheep skin cells in a gelatin-like material, called fibrin, in the form of a tube and then rhythmically pumped in nutrients necessary for cell growth using a bioreactor for up to five weeks. The pumping bioreactor provided both nutrients and “exercise” to strengthen and stiffen the tube. The bioreactor, developed with Zeeshan Syedain, a senior research associate in Tranquillo’s lab, was a key component of developing the bioartificial vessel to be stronger than a native artery so it wouldn’t burst in the patient.
The researchers then used special detergents to wash away all the sheep cells, leaving behind a cell-free matrix that does not cause immune reaction when implanted. When the vessel graft replaced a part of the pulmonary artery in three lambs at five weeks of age, the implanted vessels were soon populated by the lambs’ own cells, causing the vessel to bend its shape and grow together with the recipient until adulthood.
“What’s important is that when the graft was implanted in the sheep, the cells repopulated the blood vessel tube matrix,” Tranquillo said. “If the cells don’t repopulate the graft, the vessel can’t grow. This is the perfect marriage between tissue engineering and regenerative medicine where tissue is grown in the lab and then, after implanting the decellularized tissue, the natural processes of the recipient’s body makes it a living tissue again.”
At 50 weeks of age, the sheep’s blood vessel graft had increased 56 percent in diameter and the amount of blood that could be pumped through the vessel increased 216 percent. The collagen protein also had increased 465 percent, proving that the vessel had not merely stretched but had actually grown. No adverse effects such as clotting, vessel narrowing, or calcification were observed.
“We saw growth and none of the bad things happened,” Tranquillo said. “The results are very encouraging.”
Tranquillo said the next step is talking with doctors to determine the feasibility of requesting approval from the Food and Drug Administration (FDA) for human clinical trials within the next few years.
Learn more: Artificial blood vessels developed in the lab can grow with the recipient
The Latest on: Artificial blood vessels
[google_news title=”” keyword=”Artificial blood vessels” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial blood vessels
- Affairs of the Hearton April 25, 2024 at 10:21 pm
Find out how biomedical engineering professor Morten Jensen is developing innovative devices to produce better outcomes in cardiovascular medicine.
- SCOTUS hears Trump immunity case in historic firston April 25, 2024 at 1:15 pm
ABC News' Linsey Davis speaks with legal journalist Cristian Farias on the Supreme Court hearing in former President Donald Trump’s immunity case and how the decision will impact the trial.
- What It Takes to Build the Unbeatable Bodyon April 25, 2024 at 12:22 pm
Read a National Geographic magazine article about elite athletes and get information, facts, and more about super performers.
- Pro-Palestine college protests escalate nationwideon April 25, 2024 at 6:33 am
The U.S. military has begun to build the long-awaited port and causeway off the coast of Gaza that will establish a maritime corridor to bring humanitarian aid into Gaza, the Pentagon said Thursday.
- Ivy League stress expert: This ‘underrated' skill can help you beat burnout and be happier at work–here's howon April 24, 2024 at 4:08 am
High achievers treat stressful situations as surmountable challenges instead of defaulting to fight-or-flight mode, says researcher and author Kandi Wiens.
- Best Delta 9 Gummies: 7 THC Edibles of 2024on April 24, 2024 at 4:00 am
Check out our latest picks for the best Delta 9 gummies of 2024. Ranging from best full strength to gummies for beginners.
- Black Skincare for Men: 10 Best Products of 2024on April 23, 2024 at 1:02 pm
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. There are two main types of melanin in our skin, affecting which skin ...
- Expertise and empathy: Team approach wins the day for colon cancer patienton April 22, 2024 at 4:59 pm
She had assumed the cause was hemorrhoids (a swelling of veins or blood vessels inside and around the anus and ... which removes a patient’s colon and rectum and creates an “artificial rectum” in the ...
- Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseaseson April 18, 2024 at 12:46 pm
Cardiovascular diseases, including stroke and myocardial infarction, are the world's leading causes of mortality, accounting for over 18 million deaths a year.
via Bing News